Non-specific Response to H1N1 Vaccine
Completed
- Conditions
- Influenza H1N1
- Registration Number
- NCT01178918
- Lead Sponsor
- The University Clinic of Pulmonary and Allergic Diseases Golnik
- Brief Summary
This is a prospective observational study with recruitment of healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
The purpose of this study is to evaluate certain safety aspects of adjuvanted influenza H1N1 vaccines.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 14
Inclusion Criteria
- Recipients of H1N1 influenza vaccine.
- Healthy individuals with no signs of influenza or other infectious disease.
Exclusion Criteria
- Signs of influenza or other infectious disease in 1 month before study participation.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method T Cell Immune response monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination At 11 weeks after vaccination.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Clinic of Respiratory and Allergic Diseases
🇸🇮Golnik, Slovenia